Fresenius Medical Care (NYSE:FMS) Price Target Raised to $25.00

Fresenius Medical Care (NYSE:FMS) had its target price hoisted by Truist Financial from $23.00 to $25.00 in a research note issued to investors on Monday,Benzinga reports. Truist Financial currently has a hold rating on the stock.

A number of other equities analysts also recently issued reports on FMS. Berenberg Bank assumed coverage on Fresenius Medical Care in a report on Wednesday, November 6th. They issued a “buy” rating and a $25.60 price target for the company. StockNews.com began coverage on shares of Fresenius Medical Care in a research note on Friday, January 3rd. They set a “strong-buy” rating for the company. Finally, Bank of America upgraded Fresenius Medical Care from an “underperform” rating to a “neutral” rating in a research report on Monday, December 2nd.

Fresenius Medical Care Trading Down 1.2 %

NYSE FMS opened at $22.40 on Monday. The company has a quick ratio of 1.02, a current ratio of 1.37 and a debt-to-equity ratio of 0.42. The firm has a 50 day moving average of $22.39 and a two-hundred day moving average of $20.73. The stock has a market capitalization of $13.14 billion, a PE ratio of 18.51, a price-to-earnings-growth ratio of 0.95 and a beta of 0.92. Fresenius Medical Care has a 52 week low of $17.93 and a 52 week high of $24.31.

Institutional Trading of Fresenius Medical Care

Several hedge funds and other institutional investors have recently made changes to their positions in FMS. GAMMA Investing LLC raised its holdings in Fresenius Medical Care by 43.3% during the fourth quarter. GAMMA Investing LLC now owns 7,164 shares of the company’s stock worth $162,000 after purchasing an additional 2,166 shares in the last quarter. JPMorgan Chase & Co. lifted its holdings in shares of Fresenius Medical Care by 18.2% in the 3rd quarter. JPMorgan Chase & Co. now owns 9,902 shares of the company’s stock valued at $211,000 after buying an additional 1,528 shares during the period. Franklin Resources Inc. boosted its stake in shares of Fresenius Medical Care by 3.3% in the third quarter. Franklin Resources Inc. now owns 74,640 shares of the company’s stock valued at $1,490,000 after buying an additional 2,386 shares in the last quarter. Wilmington Savings Fund Society FSB acquired a new position in Fresenius Medical Care during the third quarter worth $38,000. Finally, MML Investors Services LLC raised its position in Fresenius Medical Care by 5.3% in the third quarter. MML Investors Services LLC now owns 15,019 shares of the company’s stock worth $320,000 after acquiring an additional 753 shares in the last quarter. Hedge funds and other institutional investors own 8.37% of the company’s stock.

About Fresenius Medical Care

Fresenius Medical Care AG provides dialysis and related services for individuals with renal diseases in Germany, North America, and internationally. The company offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure.